We were told that in 2019 there would be three high value data readouts, where each one would be company transformational. One of these readouts has come and gone and the SP has gone backwards.
With respect to one of the other two read-outs (efficacy of of GDC-0084) we already have been told that it has shown to reduce rumours in certain patients. This Information is already built into the current SP. I truly believe that a confirmatory announcement later on this year with respect to this will have no material effect on the SP.
Therefore, this is something else going on holding back the SP. The market rarely gets it wrong.
I too am troubled by the SP.
KZA Price at posting:
41.0¢ Sentiment: Hold Disclosure: Held
